Implementation of a System-level Tobacco Treatment Intervention
The proposed study plans to adapt and study the implementation and effectiveness of integrating Clinical and Community Effort Against Secondhand smoke Exposure (CEASE) into the thoracic oncology setting using mixed methods.
Checked against the public recordLast updated Apr 16, 2026 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Supportive Care
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Dana-Farber Cancer Institute
- Interventions being studied
- Other: CEASE; Other: Usual Care Tobacco Treatment Services
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Age ≥ 18 * Have an actual or potential diagnosis of thoracic malignancy * Able to read and write in English. * Current or recent former smoker (defined as having smoked within past 6 months) * Must have an active telephone number. Exclusion Criteria: * Former smoker greater than 6 months. * Have any of the below conditions needing immediate medical intervention * Hypercalcemia causing lethargy and confusion, * Acute respiratory distress * Dehydration * Hypotension
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Brigham and Women's HospitalBoston, Massachusetts
- Dana Farber Cancer InstituteBoston, Massachusetts
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Apr 16, 2026. Always confirm current availability with the study team.